Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
PLx Pharma, Inc. (PLXPQ) had Receiveable Turnover of 2.78 for the most recently reported fiscal quarter, ending 2022-09-30.
| Income Statement Financials | |
$0.39M |
|
$-8.50M |
|
$1.46M |
|
$-1.07M |
|
$11.22M |
|
$-10.84M |
|
$2.34M |
|
$-8.50M |
|
$-8.50M |
|
$-8.50M |
|
$-8.50M |
|
$-8.50M |
|
$-8.50M |
|
$-10.84M |
|
$-10.78M |
|
28.60M |
|
28.60M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$30.22M |
|
$0.77M |
|
$3.00M |
|
$33.22M |
|
$6.31M |
|
-- |
|
$16.73M |
|
$23.04M |
|
$10.19M |
|
$8.13M |
|
$10.19M |
|
29.14M |
|
| Cash Flow Statement Financials | |
$-45.97M |
|
-- |
|
$2.42M |
|
$69.39M |
|
$25.83M |
|
$-43.56M |
|
$3.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-278.24% |
|
-2808.03% |
|
-2808.03% |
|
-- |
|
-2201.30% |
|
-2201.30% |
|
$-45.97M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.46 |
|
|
Receiveable Turnover |
2.78 |
32.41 |
|
-83.41% |
|
-104.57% |
|
-25.57% |
|
-83.41% |
|
$0.35 |
|
$-1.61 |
|
$-1.61 |
|